title: Pharmacologically assisted treatment of opioid-dependent youth.
abstract: Opioid misuse, abuse, and dependence are global problems whose patterns vary across cultures. In the USA, the non-medical use of prescription opioids has become particularly serious because of its association with addiction and overdose death. Agonist and antagonist medications have been shown to be effective for opioid-dependent adults, and there is a growing body of data that they are also effective for youth. Here, we summarize evidence that detoxification alone results in high rates of treatment dropout and relapse but that the limited but growing data on the extended use of medication-assisted treatment for opioid-dependent youth have been positive. The implementation of medication-assisted treatment as a standard practice is feasible, easily integrated with counseling or psychotherapy, and has potential to greatly improve outcomes. Although concerns about safety and efficacy with youth require more research, and we do not advocate indefinite maintenance, we suggest that opioid-dependent youth should be considered as candidates for medication-assisted treatment delivered in a comprehensive, developmentally appropriate context, beginning at the first episode of care, with the strength of the recommendation to use medication increasing with each care episode.
authors.affiliation: Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 600 Public Ledger Building, 150 South Independence Mall West, Philadelphia, PA, 19106-3413, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Pecoraro
authors.forename: Marc
authors.initials: M
authors.lastname: Fishman
authors.forename: Michelle
authors.initials: M
authors.lastname: Ma
authors.forename: Gvantsa
authors.initials: G
authors.lastname: Piralishvili
authors.forename: George E
authors.initials: GE
authors.lastname: Woody
mesh_terms: D000293:Adolescent; D000701:Analgesics, Opioid / Q000819:agonists*; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000628:therapy; D011613:Psychotherapy
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists
references.citation: Drug Alcohol Depend. 2006 Sep 1;84(1):48-55
references.pmid: 16388919
references.citation: Drug Alcohol Rev. 2006 Mar;25(2):167-71
references.pmid: 16627307
references.citation: Psychopharmacology (Berl). 2006 Nov;189(1):37-46
references.pmid: 16972105
references.citation: Subst Use Misuse. 2012 Jun;47(7):861-3
references.pmid: 22468632
references.citation: Addict Behav. 2011 Dec;36(12):1233-9
references.pmid: 21880431
references.citation: F1000 Med Rep. 2011 Jan 14;3:1
references.pmid: 21399758
references.citation: Drug Alcohol Depend. 2009 Jan 1;99(1-3):141-9
references.pmid: 18818027
references.citation: Addict Biol. 2003 Sep;8(3):337-42
references.pmid: 13129836
references.citation: Drug Alcohol Depend. 1998 Nov 1;52(3):257-60
references.pmid: 9839152
references.citation: JAMA. 2008 Nov 5;300(17):2003-11
references.pmid: 18984887
references.citation: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006749
references.pmid: 19370651
references.citation: Curr Psychiatry Rep. 2000 Dec;2(6):527-30
references.pmid: 11123006
references.citation: Int J Drug Policy. 2012 Jan;23(1):37-44
references.pmid: 21689917
references.citation: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007210
references.pmid: 19370679
references.citation: Curr Opin Psychiatry. 2006 May;19(3):266-70
references.pmid: 16612211
references.citation: Addiction. 2003 Apr;98(4):453-62
references.pmid: 12653815
references.citation: Arch Gen Psychiatry. 2012 Sep;69(9):973-81
references.pmid: 22945623
references.citation: Ann N Y Acad Sci. 1978;311:153-64
references.pmid: 283716
references.citation: J Acquir Immune Defic Syndr (1988). 1993 Sep;6(9):1049-56
references.pmid: 8340896
references.citation: JAMA. 1965 Aug 23;193:646-50
references.pmid: 14321530
references.citation: Arch Gen Psychiatry. 2009 Oct;66(10):1108-15
references.pmid: 19805701
references.citation: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002209
references.pmid: 19588333
references.citation: NIDA Res Monogr. 1976 Jul;(8):82-3
references.pmid: 792705
references.citation: J Subst Abuse Treat. 2012 Jan;42(1):35-44
references.pmid: 21940134
references.citation: Curr Psychiatry Rep. 2010 Oct;12(5):448-53
references.pmid: 20640538
references.citation: Curr Psychiatry Rep. 2004 Oct;6(5):339-46
references.pmid: 15355756
references.citation: Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27
references.pmid: 12738347
references.citation: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003409
references.pmid: 16034898
references.citation: J Pharmacol Exp Ther. 1996 Feb;276(2):449-59
references.pmid: 8632309
references.citation: Lancet. 2011 Apr 30;377(9776):1506-13
references.pmid: 21529928
references.citation: Drug Alcohol Depend. 1997 Apr 14;45(1-2):81-91
references.pmid: 9179510
references.citation: Addiction. 2010 Sep;105(9):1669-76
references.pmid: 20626723
references.citation: Addiction. 2007 Jul;102(7):1164-5
references.pmid: 17498182